GNRH1 and obesity due to melanocortin 4 receptor deficiency: Patients undergoing a long-term treatment of GnRHa (i.e., over 6 months) may have decreased muscle content, increased body fat rate, and trunk/limb fat ratio 22, suggesting that high GnRH level might be positively associated with obesity.